CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Caffeine patents expire, and what generic alternatives are available?
Caffeine is a drug marketed by Am Regent, Eugia Pharma, Exela Pharma Science, Fresenius Kabi Usa, Micro Labs, Sagent Pharms, Sun Pharm, and Exela Pharma. and is included in thirteen NDAs.
The generic ingredient in CAFFEINE is caffeine citrate. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the caffeine citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Caffeine
A generic version of CAFFEINE was approved as caffeine citrate by EXELA PHARMA SCIENCE on September 21st, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAFFEINE?
- What are the global sales for CAFFEINE?
- What is Average Wholesale Price for CAFFEINE?
Summary for CAFFEINE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for CAFFEINE |
| DailyMed Link: | CAFFEINE at DailyMed |
US Patents and Regulatory Information for CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 077906-001 | May 15, 2007 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 090077-001 | Sep 30, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | CAFFEINE CITRATE | caffeine citrate | SOLUTION;INTRAVENOUS | 077997-001 | Jul 20, 2007 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sagent Pharms | CAFFEINE CITRATE | caffeine citrate | SOLUTION;ORAL | 091102-001 | Aug 29, 2012 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
